A detailed history of State Street Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, State Street Corp holds 1,273,498 shares of HRMY stock, worth $49.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,273,498
Previous 1,295,544 1.7%
Holding current value
$49.8 Million
Previous $43.5 Million 11.68%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$28.81 - $33.01 $635,145 - $727,738
-22,046 Reduced 1.7%
1,273,498 $38.4 Million
Q1 2024

May 15, 2024

SELL
$29.93 - $35.06 $1.94 Million - $2.28 Million
-64,903 Reduced 4.77%
1,295,544 $43.5 Million
Q4 2023

Feb 14, 2024

BUY
$19.2 - $33.78 $2.55 Million - $4.49 Million
132,986 Added 10.83%
1,360,447 $43.9 Million
Q3 2023

Nov 14, 2023

BUY
$31.89 - $39.03 $2.76 Million - $3.38 Million
86,527 Added 7.58%
1,227,461 $40.2 Million
Q2 2023

Aug 14, 2023

BUY
$30.5 - $37.4 $2.97 Million - $3.64 Million
97,337 Added 9.33%
1,140,934 $40.1 Million
Q1 2023

May 15, 2023

BUY
$30.8 - $53.92 $2.18 Million - $3.82 Million
70,814 Added 7.28%
1,043,597 $34.1 Million
Q4 2022

Feb 14, 2023

SELL
$45.4 - $60.91 $4.72 Million - $6.34 Million
-104,043 Reduced 9.66%
972,783 $53.6 Million
Q3 2022

Nov 15, 2022

BUY
$42.06 - $55.45 $5.57 Million - $7.35 Million
132,491 Added 14.03%
1,076,826 $47.7 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $52.15 $3.9 Million - $6.06 Million
116,154 Added 14.03%
944,335 $46.1 Million
Q1 2022

May 16, 2022

BUY
$33.14 - $51.13 $1.74 Million - $2.68 Million
52,498 Added 6.77%
828,181 $40.3 Million
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $12.9 Million - $16.6 Million
378,825 Added 95.46%
775,683 $33.1 Million
Q3 2021

Nov 15, 2021

BUY
$25.68 - $38.61 $2.42 Million - $3.63 Million
94,068 Added 31.07%
396,858 $15.2 Million
Q2 2021

Aug 16, 2021

BUY
$25.96 - $33.44 $5.59 Million - $7.2 Million
215,312 Added 246.13%
302,790 $8.55 Million
Q1 2021

May 17, 2021

BUY
$27.56 - $40.37 $129,532 - $189,739
4,700 Added 5.68%
87,478 $2.89 Million
Q4 2020

Feb 16, 2021

BUY
$31.74 - $51.34 $2.63 Million - $4.25 Million
82,778 New
82,778 $2.99 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.31B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.